CFDA Conducted Fewer Foreign Inspections in 2016

International Pharmaceutical Regulatory Monitor
A A
China’s Food and Drug Administration only carried out a fraction of the dozens of planned GMP inspections of foreign sites last year.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor